Tick-Borne Nairoviruses Use OTU Proteases to Evade Human Antiviral Signals
Researchers have identified how tick-borne nairoviruses, including emerging threats like the Pacific Coast Tick nairovirus, evade human immune responses. These viruses use specialized enzymes called OTU proteases to remove protein tags that would otherwise trigger an immune alarm.
Why it matters
Understanding these viral mechanisms is critical for developing medical countermeasures against emerging tick-borne diseases that are spreading globally.
Summer is peak tick season, and with it comes familiar threats like Lyme disease and Rocky Mountain spotted fever. But scientists say another group of tick‑borne pathogens is quietly gaining ground: nairoviruses, a diverse family of negative‑sense RNA viruses carried by ticks across Asia, Europe, Africa—and now the western United States. Several nairoviruses can infect humans, causing high fevers, severe headaches, and, in some cases, organ dysfunction. One member of the family, Crimean‑Congo hemorrhagic fever virus (CCHFV), is often fatal and considered a global‑level threat.
The content is a factual summary of scientific research published in a peer-reviewed journal.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in